Form D · Pharmaceuticals
Lumena Pharmaceuticals, Inc.
San Diego, CA · CIK 0001513157
Offering snapshot reported Mar 19, 2014 · SEC filing
- Reported sold
- $45.5M Offering amount: $45.5M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2014 | Initial | $45,499,993 | No comparison | 13 | SEC filing |
| May 24, 2012 | Amendment | $2,550,150 | $150vs Feb 8, 2012 | 6 | SEC filing |
| Feb 8, 2012 | Amendment | $2,550,000 | $2,050,000vs Jun 16, 2011 | 6 | SEC filing |
| Jun 16, 2011 | Amendment | $500,000 | $250,000vs Feb 17, 2011 | 4 | SEC filing |
| Feb 17, 2011 | Initial | $250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213918
Securities offered consist of convertible preferred stock and the common stock issuable upon conversion of the preferred stock.
Source: Form D, filed Mar 19, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Alexander | Director |
| Alejandro Dorenbaum | Executive |
| Susan E. Dube | Executive |
| Howard E. Greene | Director |
| Ted Greene | Director |
| Edward E. Greene | Director |
| Michael Grey | Director, Executive |
| Bradley T. Keller | Executive |
| Ciara Kennedy | Executive |
| Rosina Maar Pavia | Director |
| Edward Mathers | Director |
| John P. Mc Kearn | Director |
| Alana B. Mc Nulty | Executive |
| David R. Savello | Director |
| Ford S. Worthy | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
12531 High Bluff Drive, Suite 110
San Diego, CA, 92130
San Diego, CA, 92130